nec Search Results


96
Selleck Chemicals necrostatin 2 racemate
Necrostatin 2 Racemate, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nec/Nec-1s/pm36329033-227-0-19
Average 96 stars, based on 1 article reviews
necrostatin 2 racemate - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

97
MedChemExpress necrostatin
FAK controls necroptotic cell death in macrophages during Mtb infection. (A) THP-1, THP-FAKi, and THP-FAK + macrophages were infected with Mtb at an MOI of 10, and cell lysates were prepared at the indicated days post-infection (d.p.i.). Total and cleaved caspase 3, and total FAK protein levels were analyzed by western blotting. Non-infected THP-1 cell lysates were used as a negative control for caspase 3 activation, while lysates containing cleaved caspase-3 (#9663, Cell Signaling Technologies) were used as a positive control. β-tubulin was used as loading control. (B) THP-1, THP-FAKi, and THP-FAK + macrophages were infected as in (A) and at the indicated days post-infection, cells were stained with annexin V and FVS780. Stained cells were analyzed by flow cytometry to quantify the percentage of healthy, apoptotic, and necrotic cells as described in the Methods. (C) THP-1, THP-FAKi, and THP-FAK + macrophages were infected with Mtb at an MOI of 10, and lactate dehydrogenase (LDH) released in culture supernatants were assessed using the CYQUANT LDH kit at indicated days post-infection. The amount of LDH in the supernatant is proportional to the measured absorbance at 490 nm. (D) THP-1, THP-FAKi and THP-FAK + macrophages were mock treated or pre-treated with 1 µg/ml LPS for 4 h, followed by treatment with 5 µM nigericin for 24 h Macrophage viability was assessed using the Cell Titre-Glo assay. (E–G) THP-1, THP-FAKi, and/or THP-FAK + macrophages were mock treated or pre-treated with (E) <t>necrostatin-1s</t> <t>(Nec-1s,</t> 10 µM), (F) GSK-872 (5 µM), or (G) necrosulfonamide (NSA, 10 µM) for 24 h Cells were then infected with Mtb at an MOI of 10 for 6 days, and cell viability was assessed using the Cell Titer-Glo assay. Error bars represent the mean ± SD of three independent biological replicates. * p < 0.05, *** p < 0.001, ns , non-significant.
Necrostatin, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nec/Necrostatin+2/pmc08564185-70-11-6
Average 97 stars, based on 1 article reviews
necrostatin - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

99
MedChemExpress necrostatin 1
FAK controls necroptotic cell death in macrophages during Mtb infection. (A) THP-1, THP-FAKi, and THP-FAK + macrophages were infected with Mtb at an MOI of 10, and cell lysates were prepared at the indicated days post-infection (d.p.i.). Total and cleaved caspase 3, and total FAK protein levels were analyzed by western blotting. Non-infected THP-1 cell lysates were used as a negative control for caspase 3 activation, while lysates containing cleaved caspase-3 (#9663, Cell Signaling Technologies) were used as a positive control. β-tubulin was used as loading control. (B) THP-1, THP-FAKi, and THP-FAK + macrophages were infected as in (A) and at the indicated days post-infection, cells were stained with annexin V and FVS780. Stained cells were analyzed by flow cytometry to quantify the percentage of healthy, apoptotic, and necrotic cells as described in the Methods. (C) THP-1, THP-FAKi, and THP-FAK + macrophages were infected with Mtb at an MOI of 10, and lactate dehydrogenase (LDH) released in culture supernatants were assessed using the CYQUANT LDH kit at indicated days post-infection. The amount of LDH in the supernatant is proportional to the measured absorbance at 490 nm. (D) THP-1, THP-FAKi and THP-FAK + macrophages were mock treated or pre-treated with 1 µg/ml LPS for 4 h, followed by treatment with 5 µM nigericin for 24 h Macrophage viability was assessed using the Cell Titre-Glo assay. (E–G) THP-1, THP-FAKi, and/or THP-FAK + macrophages were mock treated or pre-treated with (E) <t>necrostatin-1s</t> <t>(Nec-1s,</t> 10 µM), (F) GSK-872 (5 µM), or (G) necrosulfonamide (NSA, 10 µM) for 24 h Cells were then infected with Mtb at an MOI of 10 for 6 days, and cell viability was assessed using the Cell Titer-Glo assay. Error bars represent the mean ± SD of three independent biological replicates. * p < 0.05, *** p < 0.001, ns , non-significant.
Necrostatin 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nec/Necrostatin-1/pmc13462342-98-31-36
Average 99 stars, based on 1 article reviews
necrostatin 1 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

94
TargetMol necrostatin 1
FAK controls necroptotic cell death in macrophages during Mtb infection. (A) THP-1, THP-FAKi, and THP-FAK + macrophages were infected with Mtb at an MOI of 10, and cell lysates were prepared at the indicated days post-infection (d.p.i.). Total and cleaved caspase 3, and total FAK protein levels were analyzed by western blotting. Non-infected THP-1 cell lysates were used as a negative control for caspase 3 activation, while lysates containing cleaved caspase-3 (#9663, Cell Signaling Technologies) were used as a positive control. β-tubulin was used as loading control. (B) THP-1, THP-FAKi, and THP-FAK + macrophages were infected as in (A) and at the indicated days post-infection, cells were stained with annexin V and FVS780. Stained cells were analyzed by flow cytometry to quantify the percentage of healthy, apoptotic, and necrotic cells as described in the Methods. (C) THP-1, THP-FAKi, and THP-FAK + macrophages were infected with Mtb at an MOI of 10, and lactate dehydrogenase (LDH) released in culture supernatants were assessed using the CYQUANT LDH kit at indicated days post-infection. The amount of LDH in the supernatant is proportional to the measured absorbance at 490 nm. (D) THP-1, THP-FAKi and THP-FAK + macrophages were mock treated or pre-treated with 1 µg/ml LPS for 4 h, followed by treatment with 5 µM nigericin for 24 h Macrophage viability was assessed using the Cell Titre-Glo assay. (E–G) THP-1, THP-FAKi, and/or THP-FAK + macrophages were mock treated or pre-treated with (E) <t>necrostatin-1s</t> <t>(Nec-1s,</t> 10 µM), (F) GSK-872 (5 µM), or (G) necrosulfonamide (NSA, 10 µM) for 24 h Cells were then infected with Mtb at an MOI of 10 for 6 days, and cell viability was assessed using the Cell Titer-Glo assay. Error bars represent the mean ± SD of three independent biological replicates. * p < 0.05, *** p < 0.001, ns , non-significant.
Necrostatin 1, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nec/Necrostatin-1/pmc10853205-228-5-10
Average 94 stars, based on 1 article reviews
necrostatin 1 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
TargetMol necrosis inhibitor necrostatin 1 nec 1
Fig. 7 MiR-375 attenuates the stemness of GC cells mainly through inducing ferroptosis. A CD44+ sub-population was examined in GC cells with miR-375 overexpression plus Fer-1, Z-VAD-FMK, <t>or</t> <t>Nec-1</t> treatment. Data are presented as the mean ± SD, n ≥3, *p < 0.05, **p < 0.01 vs LV3- NC+DMSO; ##p < 0.01, ###p < 0.001 vs LV3-miR-375+DMSO. B The expression of stemness markers was detected in the cells depicted in A. C The expression of stemness markers was determined in GC cells with SLC7A11 knockdown plus Fer-1 treatment or not. D The inhibition ratio of erastin was measured in WT and ER cells. Data are presented as the mean ±ean ar ≥3, **p < 0.01, ***p < 0.001 vs WT or ER. E CD44+ sub- population was assessed in WT and ER cells with miR-375 overexpression or miR-NC. Data are presented as the mean ±re pre ≥3, **p < 0.01 vs control+miR-NC; ns, no significance. F The expression of stemness markers was examined in the cells described in E. G Sphere-formation ability was evaluated in the cells depicted in E
Necrosis Inhibitor Necrostatin 1 Nec 1, supplied by TargetMol, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nec/Necrostatin-1/pm34090492-65-9-16
Average 96 stars, based on 1 article reviews
necrosis inhibitor necrostatin 1 nec 1 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

92
MedChemExpress necroptosis inhibitor
Fig. 7 MiR-375 attenuates the stemness of GC cells mainly through inducing ferroptosis. A CD44+ sub-population was examined in GC cells with miR-375 overexpression plus Fer-1, Z-VAD-FMK, <t>or</t> <t>Nec-1</t> treatment. Data are presented as the mean ± SD, n ≥3, *p < 0.05, **p < 0.01 vs LV3- NC+DMSO; ##p < 0.01, ###p < 0.001 vs LV3-miR-375+DMSO. B The expression of stemness markers was detected in the cells depicted in A. C The expression of stemness markers was determined in GC cells with SLC7A11 knockdown plus Fer-1 treatment or not. D The inhibition ratio of erastin was measured in WT and ER cells. Data are presented as the mean ±ean ar ≥3, **p < 0.01, ***p < 0.001 vs WT or ER. E CD44+ sub- population was assessed in WT and ER cells with miR-375 overexpression or miR-NC. Data are presented as the mean ±re pre ≥3, **p < 0.01 vs control+miR-NC; ns, no significance. F The expression of stemness markers was examined in the cells described in E. G Sphere-formation ability was evaluated in the cells depicted in E
Necroptosis Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nec/Necrostatin-7/pmc11617880-382-10-27
Average 92 stars, based on 1 article reviews
necroptosis inhibitor - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

92
Proteintech cat
Fig. 7 MiR-375 attenuates the stemness of GC cells mainly through inducing ferroptosis. A CD44+ sub-population was examined in GC cells with miR-375 overexpression plus Fer-1, Z-VAD-FMK, <t>or</t> <t>Nec-1</t> treatment. Data are presented as the mean ± SD, n ≥3, *p < 0.05, **p < 0.01 vs LV3- NC+DMSO; ##p < 0.01, ###p < 0.001 vs LV3-miR-375+DMSO. B The expression of stemness markers was detected in the cells depicted in A. C The expression of stemness markers was determined in GC cells with SLC7A11 knockdown plus Fer-1 treatment or not. D The inhibition ratio of erastin was measured in WT and ER cells. Data are presented as the mean ±ean ar ≥3, **p < 0.01, ***p < 0.001 vs WT or ER. E CD44+ sub- population was assessed in WT and ER cells with miR-375 overexpression or miR-NC. Data are presented as the mean ±re pre ≥3, **p < 0.01 vs control+miR-NC; ns, no significance. F The expression of stemness markers was examined in the cells described in E. G Sphere-formation ability was evaluated in the cells depicted in E
Cat, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nec/PCSK2+Antibody/pmc11253548-7-4-2
Average 92 stars, based on 1 article reviews
cat - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

91
OriGene pcsk1 myc ddk
Fig. 7 MiR-375 attenuates the stemness of GC cells mainly through inducing ferroptosis. A CD44+ sub-population was examined in GC cells with miR-375 overexpression plus Fer-1, Z-VAD-FMK, <t>or</t> <t>Nec-1</t> treatment. Data are presented as the mean ± SD, n ≥3, *p < 0.05, **p < 0.01 vs LV3- NC+DMSO; ##p < 0.01, ###p < 0.001 vs LV3-miR-375+DMSO. B The expression of stemness markers was detected in the cells depicted in A. C The expression of stemness markers was determined in GC cells with SLC7A11 knockdown plus Fer-1 treatment or not. D The inhibition ratio of erastin was measured in WT and ER cells. Data are presented as the mean ±ean ar ≥3, **p < 0.01, ***p < 0.001 vs WT or ER. E CD44+ sub- population was assessed in WT and ER cells with miR-375 overexpression or miR-NC. Data are presented as the mean ±re pre ≥3, **p < 0.01 vs control+miR-NC; ns, no significance. F The expression of stemness markers was examined in the cells described in E. G Sphere-formation ability was evaluated in the cells depicted in E
Pcsk1 Myc Ddk, supplied by OriGene, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nec/Pcsk1+(NM_013628)+Mouse+Tagged+ORF+Clone/pmc09859757-368-19-31
Average 91 stars, based on 1 article reviews
pcsk1 myc ddk - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

93
SiliCycle ultrapure siliabond diamine functionalized silica gel
Fig. 7 MiR-375 attenuates the stemness of GC cells mainly through inducing ferroptosis. A CD44+ sub-population was examined in GC cells with miR-375 overexpression plus Fer-1, Z-VAD-FMK, <t>or</t> <t>Nec-1</t> treatment. Data are presented as the mean ± SD, n ≥3, *p < 0.05, **p < 0.01 vs LV3- NC+DMSO; ##p < 0.01, ###p < 0.001 vs LV3-miR-375+DMSO. B The expression of stemness markers was detected in the cells depicted in A. C The expression of stemness markers was determined in GC cells with SLC7A11 knockdown plus Fer-1 treatment or not. D The inhibition ratio of erastin was measured in WT and ER cells. Data are presented as the mean ±ean ar ≥3, **p < 0.01, ***p < 0.001 vs WT or ER. E CD44+ sub- population was assessed in WT and ER cells with miR-375 overexpression or miR-NC. Data are presented as the mean ±re pre ≥3, **p < 0.01 vs control+miR-NC; ns, no significance. F The expression of stemness markers was examined in the cells described in E. G Sphere-formation ability was evaluated in the cells depicted in E
Ultrapure Siliabond Diamine Functionalized Silica Gel, supplied by SiliCycle, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nec/SiliaBond+Functionalized+Silica+Gels+Amine+(WAX)+nec/pmc04280077-107-0-9
Average 93 stars, based on 1 article reviews
ultrapure siliabond diamine functionalized silica gel - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
ProSci Incorporated nec
Publications concerning necroptosis in liver injury from acetaminophen toxicity
Nec, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nec/PCSK1+Antibody/pmc05136616-2-15-38
Average 90 stars, based on 1 article reviews
nec - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

95
Norcada Inc si3n4 membrane
Publications concerning necroptosis in liver injury from acetaminophen toxicity
Si3n4 Membrane, supplied by Norcada Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nec/Sample+Holder+for+Microscopy/10__1016_slash_j__mtla__2024__102311-60-12-15
Average 95 stars, based on 1 article reviews
si3n4 membrane - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

Image Search Results


FAK controls necroptotic cell death in macrophages during Mtb infection. (A) THP-1, THP-FAKi, and THP-FAK + macrophages were infected with Mtb at an MOI of 10, and cell lysates were prepared at the indicated days post-infection (d.p.i.). Total and cleaved caspase 3, and total FAK protein levels were analyzed by western blotting. Non-infected THP-1 cell lysates were used as a negative control for caspase 3 activation, while lysates containing cleaved caspase-3 (#9663, Cell Signaling Technologies) were used as a positive control. β-tubulin was used as loading control. (B) THP-1, THP-FAKi, and THP-FAK + macrophages were infected as in (A) and at the indicated days post-infection, cells were stained with annexin V and FVS780. Stained cells were analyzed by flow cytometry to quantify the percentage of healthy, apoptotic, and necrotic cells as described in the Methods. (C) THP-1, THP-FAKi, and THP-FAK + macrophages were infected with Mtb at an MOI of 10, and lactate dehydrogenase (LDH) released in culture supernatants were assessed using the CYQUANT LDH kit at indicated days post-infection. The amount of LDH in the supernatant is proportional to the measured absorbance at 490 nm. (D) THP-1, THP-FAKi and THP-FAK + macrophages were mock treated or pre-treated with 1 µg/ml LPS for 4 h, followed by treatment with 5 µM nigericin for 24 h Macrophage viability was assessed using the Cell Titre-Glo assay. (E–G) THP-1, THP-FAKi, and/or THP-FAK + macrophages were mock treated or pre-treated with (E) necrostatin-1s (Nec-1s, 10 µM), (F) GSK-872 (5 µM), or (G) necrosulfonamide (NSA, 10 µM) for 24 h Cells were then infected with Mtb at an MOI of 10 for 6 days, and cell viability was assessed using the Cell Titer-Glo assay. Error bars represent the mean ± SD of three independent biological replicates. * p < 0.05, *** p < 0.001, ns , non-significant.

Journal: Frontiers in Immunology

Article Title: Mycobacterium tuberculosis Exploits Focal Adhesion Kinase to Induce Necrotic Cell Death and Inhibit Reactive Oxygen Species Production

doi: 10.3389/fimmu.2021.742370

Figure Lengend Snippet: FAK controls necroptotic cell death in macrophages during Mtb infection. (A) THP-1, THP-FAKi, and THP-FAK + macrophages were infected with Mtb at an MOI of 10, and cell lysates were prepared at the indicated days post-infection (d.p.i.). Total and cleaved caspase 3, and total FAK protein levels were analyzed by western blotting. Non-infected THP-1 cell lysates were used as a negative control for caspase 3 activation, while lysates containing cleaved caspase-3 (#9663, Cell Signaling Technologies) were used as a positive control. β-tubulin was used as loading control. (B) THP-1, THP-FAKi, and THP-FAK + macrophages were infected as in (A) and at the indicated days post-infection, cells were stained with annexin V and FVS780. Stained cells were analyzed by flow cytometry to quantify the percentage of healthy, apoptotic, and necrotic cells as described in the Methods. (C) THP-1, THP-FAKi, and THP-FAK + macrophages were infected with Mtb at an MOI of 10, and lactate dehydrogenase (LDH) released in culture supernatants were assessed using the CYQUANT LDH kit at indicated days post-infection. The amount of LDH in the supernatant is proportional to the measured absorbance at 490 nm. (D) THP-1, THP-FAKi and THP-FAK + macrophages were mock treated or pre-treated with 1 µg/ml LPS for 4 h, followed by treatment with 5 µM nigericin for 24 h Macrophage viability was assessed using the Cell Titre-Glo assay. (E–G) THP-1, THP-FAKi, and/or THP-FAK + macrophages were mock treated or pre-treated with (E) necrostatin-1s (Nec-1s, 10 µM), (F) GSK-872 (5 µM), or (G) necrosulfonamide (NSA, 10 µM) for 24 h Cells were then infected with Mtb at an MOI of 10 for 6 days, and cell viability was assessed using the Cell Titer-Glo assay. Error bars represent the mean ± SD of three independent biological replicates. * p < 0.05, *** p < 0.001, ns , non-significant.

Article Snippet: PF-573-228 and necrostatin-1 were purchased from MedChem Express (Monmouth, NJ), while necrostatin-1s was purchased from New England Biolabs (Ipswich, MA).

Techniques: Infection, Western Blot, Negative Control, Activation Assay, Positive Control, Control, Staining, Flow Cytometry, CyQUANT Assay, Glo Assay

Expression of FAK controls Mtb survival. (A) Mtb was treated with the indicated concentrations of FAK inhibitors (in the absence of macrophages), PF-573-228 and PF-562-271, for 5 days, after which Mtb growth was assessed using the resazurin viability assay. Relative viability was normalized to 100% using untreated controls. (B) THP-1, THP-FAKi, and THP-FAK + macrophages, or (C) RAW 264.7 and RAW 264.7-FAKi macrophages were infected with Mtb-luciferase at an MOI of 10 for 6 days. Infected macrophages were lysed at the indicated time points post-infection and the resultant luminescence signal (RLU) was measured as a proxy for the relative number of viable of Mtb. (D, E) THP-1 macrophages were mock treated or pre-treated with (D) 30 µM necrostatin-1 or (E) 5 µM GSK-872 for 24 h, and subsequently infected as in (B) . Infected macrophages were lysed at the indicated time points post-infection, and the resultant luminescence signal (RLU) was measured as a proxy for the relative number of viable of Mtb. Error bars represent the mean ± SD of three independent biological replicates. ** p < 0.01, *** p < 0.001.

Journal: Frontiers in Immunology

Article Title: Mycobacterium tuberculosis Exploits Focal Adhesion Kinase to Induce Necrotic Cell Death and Inhibit Reactive Oxygen Species Production

doi: 10.3389/fimmu.2021.742370

Figure Lengend Snippet: Expression of FAK controls Mtb survival. (A) Mtb was treated with the indicated concentrations of FAK inhibitors (in the absence of macrophages), PF-573-228 and PF-562-271, for 5 days, after which Mtb growth was assessed using the resazurin viability assay. Relative viability was normalized to 100% using untreated controls. (B) THP-1, THP-FAKi, and THP-FAK + macrophages, or (C) RAW 264.7 and RAW 264.7-FAKi macrophages were infected with Mtb-luciferase at an MOI of 10 for 6 days. Infected macrophages were lysed at the indicated time points post-infection and the resultant luminescence signal (RLU) was measured as a proxy for the relative number of viable of Mtb. (D, E) THP-1 macrophages were mock treated or pre-treated with (D) 30 µM necrostatin-1 or (E) 5 µM GSK-872 for 24 h, and subsequently infected as in (B) . Infected macrophages were lysed at the indicated time points post-infection, and the resultant luminescence signal (RLU) was measured as a proxy for the relative number of viable of Mtb. Error bars represent the mean ± SD of three independent biological replicates. ** p < 0.01, *** p < 0.001.

Article Snippet: PF-573-228 and necrostatin-1 were purchased from MedChem Express (Monmouth, NJ), while necrostatin-1s was purchased from New England Biolabs (Ipswich, MA).

Techniques: Expressing, Viability Assay, Infection, Luciferase

Expression of FAK induces production of ROS to control Mtb infection. (A) THP-1, THP-FAKi, and THP-FAK + macrophages were infected with Mtb-tdTomato (red signal) for 6 days, after which cells were stained with DCFH-DA (5 μM, green signal) for 30 minutes at 37°C. Representative Bright Field and fluorescence images of uninfected and Mtb-infected (red) macrophages (green, ROS), are shown using a 20x objective. Scale bar, 100 μm. (B) THP-1 macrophages were infected and stained with DCFH-DA as in (A) and the amount of ROS production was quantified at the indicated time points post-infection using a fluorescence plate reader at 485 nm/535 nm. (C) RAW 264.7 macrophages were infected and stained as in (A) and the amount of ROS production was quantified at day 6 post-infection. (D) THP-1 and THP-FAK + macrophage were pre-treated with 10 mM N-acetyl-cysteine (NAC) or 25 µM GSK2795039 for 24 h and then infected with Mtb-luciferase at an MOI of 10. Infected macrophages were lysed at day 6 post-infection and the resultant luminescence signal was measured as a proxy for the relative number of viable of Mtb. RLU signals were normalised to mock treated THP-1 cells as 100% and depicted as % Mtb survival. (E) THP-1, THP-FAKi, and THP-FAK + macrophages were mock treated or pre-treated with 30 µM necrostatin-1 for 24 h, after which cells were infected with Mtb at MOI of 10. At indicated time points post-infection, infected macrophages were stained with DCFH-DA as in (A) and fluorescence signals for ROS production was measured. Error bars represent the mean ± SD of three independent biological replicates. * p < 0.05, *** p < 0.001.

Journal: Frontiers in Immunology

Article Title: Mycobacterium tuberculosis Exploits Focal Adhesion Kinase to Induce Necrotic Cell Death and Inhibit Reactive Oxygen Species Production

doi: 10.3389/fimmu.2021.742370

Figure Lengend Snippet: Expression of FAK induces production of ROS to control Mtb infection. (A) THP-1, THP-FAKi, and THP-FAK + macrophages were infected with Mtb-tdTomato (red signal) for 6 days, after which cells were stained with DCFH-DA (5 μM, green signal) for 30 minutes at 37°C. Representative Bright Field and fluorescence images of uninfected and Mtb-infected (red) macrophages (green, ROS), are shown using a 20x objective. Scale bar, 100 μm. (B) THP-1 macrophages were infected and stained with DCFH-DA as in (A) and the amount of ROS production was quantified at the indicated time points post-infection using a fluorescence plate reader at 485 nm/535 nm. (C) RAW 264.7 macrophages were infected and stained as in (A) and the amount of ROS production was quantified at day 6 post-infection. (D) THP-1 and THP-FAK + macrophage were pre-treated with 10 mM N-acetyl-cysteine (NAC) or 25 µM GSK2795039 for 24 h and then infected with Mtb-luciferase at an MOI of 10. Infected macrophages were lysed at day 6 post-infection and the resultant luminescence signal was measured as a proxy for the relative number of viable of Mtb. RLU signals were normalised to mock treated THP-1 cells as 100% and depicted as % Mtb survival. (E) THP-1, THP-FAKi, and THP-FAK + macrophages were mock treated or pre-treated with 30 µM necrostatin-1 for 24 h, after which cells were infected with Mtb at MOI of 10. At indicated time points post-infection, infected macrophages were stained with DCFH-DA as in (A) and fluorescence signals for ROS production was measured. Error bars represent the mean ± SD of three independent biological replicates. * p < 0.05, *** p < 0.001.

Article Snippet: PF-573-228 and necrostatin-1 were purchased from MedChem Express (Monmouth, NJ), while necrostatin-1s was purchased from New England Biolabs (Ipswich, MA).

Techniques: Expressing, Control, Infection, Staining, Fluorescence, Luciferase

Fig. 7 MiR-375 attenuates the stemness of GC cells mainly through inducing ferroptosis. A CD44+ sub-population was examined in GC cells with miR-375 overexpression plus Fer-1, Z-VAD-FMK, or Nec-1 treatment. Data are presented as the mean ± SD, n ≥3, *p < 0.05, **p < 0.01 vs LV3- NC+DMSO; ##p < 0.01, ###p < 0.001 vs LV3-miR-375+DMSO. B The expression of stemness markers was detected in the cells depicted in A. C The expression of stemness markers was determined in GC cells with SLC7A11 knockdown plus Fer-1 treatment or not. D The inhibition ratio of erastin was measured in WT and ER cells. Data are presented as the mean ±ean ar ≥3, **p < 0.01, ***p < 0.001 vs WT or ER. E CD44+ sub- population was assessed in WT and ER cells with miR-375 overexpression or miR-NC. Data are presented as the mean ±re pre ≥3, **p < 0.01 vs control+miR-NC; ns, no significance. F The expression of stemness markers was examined in the cells described in E. G Sphere-formation ability was evaluated in the cells depicted in E

Journal: Stem cell research & therapy

Article Title: MiR-375 reduces the stemness of gastric cancer cells through triggering ferroptosis.

doi: 10.1186/s13287-021-02394-7

Figure Lengend Snippet: Fig. 7 MiR-375 attenuates the stemness of GC cells mainly through inducing ferroptosis. A CD44+ sub-population was examined in GC cells with miR-375 overexpression plus Fer-1, Z-VAD-FMK, or Nec-1 treatment. Data are presented as the mean ± SD, n ≥3, *p < 0.05, **p < 0.01 vs LV3- NC+DMSO; ##p < 0.01, ###p < 0.001 vs LV3-miR-375+DMSO. B The expression of stemness markers was detected in the cells depicted in A. C The expression of stemness markers was determined in GC cells with SLC7A11 knockdown plus Fer-1 treatment or not. D The inhibition ratio of erastin was measured in WT and ER cells. Data are presented as the mean ±ean ar ≥3, **p < 0.01, ***p < 0.001 vs WT or ER. E CD44+ sub- population was assessed in WT and ER cells with miR-375 overexpression or miR-NC. Data are presented as the mean ±re pre ≥3, **p < 0.01 vs control+miR-NC; ns, no significance. F The expression of stemness markers was examined in the cells described in E. G Sphere-formation ability was evaluated in the cells depicted in E

Article Snippet: Another ferroptosis agonist sulfasalazine (SAS), pancaspase inhibitor Z-VAD-FMK, and necrosis inhibitor Necrostatin-1 (Nec-1) were purchased from TargetMol (Target Molecule Corp, USA).

Techniques: Over Expression, Expressing, Knockdown, Inhibition, Control

Publications concerning necroptosis in liver injury from acetaminophen toxicity

Journal: Cell Death Discovery

Article Title: Questions and controversies: the role of necroptosis in liver disease

doi: 10.1038/cddiscovery.2016.89

Figure Lengend Snippet: Publications concerning necroptosis in liver injury from acetaminophen toxicity

Article Snippet: Ramachandran et al . , RIPK3 morpholino protected against APAP 200 mg/kg at 6 h Nec-1 protected in vitro RIPK3 induction suggested with APAP RIPK3−/− protected at 6hr No protection at 24 h in RIPK3−/− , Polyclonal antibody Prosci Mismatched strain as controls and not littermate controls Used Morpholino to knockdown but was not detecting RIPK3 at baseline suggesting RIPK3 induction prevented with morpholino pre-treatment RIPK3 present at baseline inconsistently on blots Nec-1 s (more specific inhibitor) not used Only early time point protection No effect on APAP metabolism (GSH unchanged between tx and con).

Techniques: Molecular Weight, In Vitro, Knockdown, Immunohistochemistry, Injection, Modification, In Vivo, Binding Assay, Control, Expressing, Reverse Transcription Polymerase Chain Reaction, Staining, Membrane